These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
467 related articles for article (PubMed ID: 18180629)
1. The analgesic effect of botulinum-toxin A on postwhiplash neck pain. Braker C; Yariv S; Adler R; Badarny S; Eisenberg E Clin J Pain; 2008 Jan; 24(1):5-10. PubMed ID: 18180629 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study. Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Lew HL; Lee EH; Castaneda A; Klima R; Date E Arch Phys Med Rehabil; 2008 Jan; 89(1):75-80. PubMed ID: 18164334 [TBL] [Abstract][Full Text] [Related]
4. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder. Carroll A; Barnes M; Comiskey C Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531 [TBL] [Abstract][Full Text] [Related]
5. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. Freund BJ; Schwartz M J Rheumatol; 2000 Feb; 27(2):481-4. PubMed ID: 10685817 [TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Göbel H; Heinze A; Reichel G; Hefter H; Benecke R; Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294 [TBL] [Abstract][Full Text] [Related]
8. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study. Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study. Boon AJ; Smith J; Dahm DL; Sorenson EJ; Larson DR; Fitz-Gibbon PD; Dykstra DD; Singh JA PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study. Wittekindt C; Liu WC; Preuss SF; Guntinas-Lichius O Laryngoscope; 2006 Jul; 116(7):1168-71. PubMed ID: 16826054 [TBL] [Abstract][Full Text] [Related]
12. Comparison of 3 needle sizes for trigger point injection in myofascial pain syndrome of upper- and middle-trapezius muscle: a randomized controlled trial. Yoon SH; Rah UW; Sheen SS; Cho KH Arch Phys Med Rehabil; 2009 Aug; 90(8):1332-9. PubMed ID: 19651267 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A for the treatment of chronic neck pain after neck dissection. Vasan CW; Liu WC; Klussmann JP; Guntinas-Lichius O Head Neck; 2004 Jan; 26(1):39-45. PubMed ID: 14724905 [TBL] [Abstract][Full Text] [Related]
14. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study. Seo HG; Bang MS; Chung SG; Jung SH; Lee SU Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438 [TBL] [Abstract][Full Text] [Related]
15. Treatment of whiplash associated neck pain with botulinum toxin-A: report of 8 cases. Freund BJ; Schwartz M J Rheumatol; 1999 Mar; 26(3):756-8. PubMed ID: 10090202 [No Abstract] [Full Text] [Related]
16. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Qerama E; Fuglsang-Frederiksen A; Kasch H; Bach FW; Jensen TS Neurology; 2006 Jul; 67(2):241-5. PubMed ID: 16864815 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study. Taylor M; Silva S; Cottrell C Headache; 2008; 48(10):1476-81. PubMed ID: 19076646 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study. Hamdy RC; Montpetit K; Raney EM; Aiona MD; Fillman RR; MacKenzie W; McCarthy J; Chafetz RS; Thomas SS; Tamayo CM; Littleton AG; Ruck-Gibis J; Takahashi SN; Rinaldi M; Finley GA; Platt RW; Dahan-Oliel N J Pediatr Orthop; 2009; 29(5):427-34. PubMed ID: 19568011 [TBL] [Abstract][Full Text] [Related]
19. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial. Singh JA; Mahowald ML; Noorbaloochi S Transl Res; 2009 May; 153(5):205-16. PubMed ID: 19375681 [TBL] [Abstract][Full Text] [Related]
20. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait. Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]